Simplifying Global Compliance
Final FDA Guidance on Trial Monitoring to Give More Detail on Creating Plans
Washington Drug Letter
An upcoming final FDA guidance on risk-based monitoring of clinical investigations will include more specifics for drugmakers on developing monitoring plans, as the industry has requested.
To View This Article:
Buy This Article Now
Copyright ©2014. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing